Alzheimer's Disease: Prevention Through Dietary Interventions
Until now, drug discovery has been a research focus in Alzheimer’s disease, but the vast majority of drugs emerging from animal models have failed in humans. A more promising approach follows the lead of heart disease research: identifying risk factors in epidemiologic studies and testing means of modifying these factors in human clinical trials. The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Trial is one study following this strategy, but many more are needed. Given the high prevalence of Alzheimer’s disease, these promising avenues for research merit vigorous attention. A renewed focus on nutritional factors and on human, rather than animal, biology is needed.